Dublin, May 12, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Injection Pens - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Diabetes Injection Pens estimated at US$7.2 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at a CAGR of 6.7% over the period 2020-2027.
Type I Diabetes, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$6.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Type II Diabetes segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 10.1% CAGR
The Diabetes Injection Pens market in the U.S. is estimated at US$2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Select Competitors (Total 43 Featured):
Becton, Dickinson and Company
Eli Lilly and Company
Jiangsu Delfu medical device Co., Ltd.
Novo Nordisk A/S
Owen Mumford Ltd.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
REST OF EUROPE
REST OF ASIA-PACIFIC
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/yj2ksa
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900